Strategies that regulate LSD1 for novel therapeutics

Area of Science:

• Epigenetics
• Molecular Biology
• Biochemistry

Background:

• Histone methylation is key to chromatin structure and gene transcription.
• Lysine-specific demethylase 1 (LSD1) is overexpressed in diseases and is a therapeutic target.
• LSD1 regulates gene transcription by removing methyl groups from H3K4 and H3K9.

Purpose of the Study:

• To systematically review regulatory factors of LSD1 activity.
• To explore how transcriptional corepressor complexes influence LSD1.
• To summarize the impact of post-translational modifications and metabolites on LSD1.

Main Methods:

• Literature review of studies on LSD1 regulation.
• Analysis of protein interactions within corepressor complexes.
• Examination of post-translational modifications and metabolite effects on LSD1.

Main Results:

• LSD1 activity is dynamically regulated by multiple factors beyond its demethylase function.
• Proteins forming transcriptional corepressor complexes modulate LSD1.
• Post-translational modifications and cellular metabolites also influence LSD1 expression and activity.

Conclusions:

• Understanding LSD1 regulation is crucial for developing targeted therapies.
• LSD1's complex regulatory network involves protein interactions, PTMs, and metabolites.
• Further research into these regulatory mechanisms can uncover new therapeutic strategies for LSD1-associated diseases.